SCHEMBL16201345

SCHEMBL16201345

CCCN(C)Cc1c[nH]nc1-c1ccc(OC(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT3 O60678 1/20 0.40
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PRMT1 Q99873 1/20 0.40
PRMT8 Q9NR22 1/20 0.40
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 2/20 0.35
MAT2A P31153 3/20 0.34
KDM2B Q8NHM5 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 2/20 0.32
DRD1 P21728 1/20 0.32
CRHR1 P34998 1/20 0.32
HTT P42858 3/20 0.31
IGF1R P08069 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201184 0.89 PRMT1 (0.52) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL16201332 0.89 PRMT1 (0.51) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL16201414 0.85 PRMT1 (0.41) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL16201361 0.84 PRMT6 (0.45) PRMT6PRMT1KDM2BSCN5A
SCHEMBL16201419 0.84 MEN1 (0.41) MAPTALDH1A1GAARAB9ALMNA
SCHEMBL16201317 0.83 KDM4E (0.34) MAPTALDH1A1GAALMNAMAPK1
SCHEMBL16201453 0.83 SCN9A (0.38)
SCHEMBL16201342 0.82 PRMT1 (0.39) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL16201421 0.82 MEN1 (0.36) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL16201436 0.81 ALDH1A1 (0.42) MAPTALDH1A1GAARAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776972-B2 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof EPIZYME INC. (US) 2017-10-03 US disclosed
US-9346761-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2016-05-24 US disclosed
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-05-19 US disclosed
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT3 2/4885CARM1 11/4885PRMT6 4/4885
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT3 2/4885CARM1 12/4885PRMT6 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.